Ebola virus disease (EVD) news, resources and funding for global health researchers

Ebola hemorrhagic fever is an acute viral disease that often leads to severe illness and death in humans and other primates. The infection typically affects multiple organs in the body and is often accompanied by hemorrhage. Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact.

Scientists employed and funded by NIH's National Institute of Allergy and Infectious Diseases (NIAID) have been working for decades to develop tests to diagnose Ebola virus early, therapies to treat illness caused by the virus, and vaccines to prevent infection. Because of the past outbreaks in West Africa, NIAID's Vaccine Research Center is supporting the development and testing of investigational vaccines. NIAID is also researching the long-term health effects of Ebola on survivors.

Fogarty is supporting grants to plan research training and capacity building programs focused on emerging viral epidemics in collaboration with institutions in Guinea, Liberia and Sierra Leone.

Top News

• Experimental NIH Sudan virus vaccine protects macaques
  NIH/NIAID news, February 3, 2023
• Ebola Vaccine Regimens Safe, Immunogenic in Adults and Children
  NIH/NIAID news, December 14, 2022
  
• The U.S. Response to Ebola Outbreaks in Uganda
  CDC news, October 18, 2022
  
• WHO makes new recommendations for Ebola treatments, calls for improved access
  WHO News, August 19, 2022
• Podcast: Risk Prediction for Pediatric Patients with Suspected Ebola Virus Disease
  CDC, July 20, 2022
  • Related article: Risk Prediction Score for Pediatric Patients with Suspected Ebola Virus Disease
    Emerging Infectious Diseases, June 2022
• The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone, Fogarty Fellows Samuel Ficenec and Donald Grant lead authors
  BMC Infectious Diseases, July 18, 2022
• Rapid diagnostic tests versus RT–PCR for Ebola virus infections: a systematic review and meta-analysis
  Bulletin of the World Health Organization, July 1, 2022
• An Ebola therapy two decades in the making
  NIH researcher Dr Nancy Sullivan led development of cutting-edge treatment
  NIH Intramural Research Program blog post, February 10, 2021
  

Related Fogarty News and Information

• Climate change accelerates Ebola outbreak frequency
  Nov/Dec 2022 Global Health Matters
• Focus: Fogarty’s response to Ebola: Where are we now?
  Global Health Matters, July / August 2022
  • Building a bench of researchers in post-Ebola Liberia
    
  • South-South partnership bolsters the fight against viral disease in West Africa
    
  • Developing a new generation of researchers in Sierra Leone
  • Opinion: Fogarty’s continuing support of Ebola research is a point of pride

NIH News and Resources

• About Ebola from NIAID
• About Ebola from NIH's MedlinePlus
  

Other US Government Resources

• U.S. Centers for Disease Control and Prevention (CDC) Ebola resources:
• CDC on Ebola (Ebola Virus Disease)
• CDC information for healthcare workers
• CDC Global Health Security Agenda
  
• United States Agency for International Development (USAID):
• USAID Ebola news and resources
  

Other Online Resources

• Ebola virus disease (EVD) information and resources
  from the World Health Organization (WHO)
• Ebola Resource Centre
  The Lancet
• Ebola toolbox
  from MEDBOX, the Aid Library, administered by the Medical Mission Institute, the Association for Overseas Medical Services, a non-profit advisory organization for international health, based in Würzburg, Germany
  

Updated February 3, 2023